COLVIN J:
1 On 30 June 2020, the 15% shareholding of Mr Walid Sharif in Vitruvian Investments Pty Ltd (Vitruvian) was cancelled by resolution of the sole director of the company, Mr Jonathan Gregory. Two weeks later Vitruvian issued further shares to its two remaining shareholders. Two months after that, the shares on issue by Vitruvian were split with 178 shares being issued for every share. In consequence, J & S Gregory Pty Ltd (a company controlled by Mr Gregory) became the holder of 18 million shares in Vitruvian and Mr Andrew Larsen became the holder of two million shares. A week later three million shares were issued to VFormTrain Pty Ltd as trustees for employees of Vitruvian for the purpose of establishing an employee share scheme. Thereafter, there were further share issues by Vitruvian in 2021 and 2022 to the existing and new shareholders.
2 Mr Sharif claimed that the conduct of the affairs of Vitruvian had been oppressive to him. He also claimed that J & S Gregory Pty Ltd and VFormTrain Pty Ltd benefitted from that conduct.
3 In July 2022, Mr Sharif commenced proceedings in this Court against Vitruvian, Mr Gregory, J & S Gregory Pty Ltd and VFormTrain Pty Ltd (together, the Vitruvian Defendants). By those proceedings Mr Sharif sought relief on the basis of alleged contravention of s 232 of the Corporations Act 2001 (Cth), alternatively breach of a shareholders agreement (Oppression Claim). He sought orders reinstating him as a 15% shareholder of Vitruvian, alternatively damages.
4 Mr Sharif also claimed to be the joint inventor, with Mr Gregory, of a fitness device for which patent applications had been made by Vitruvian and sought relief on that basis (Patent Claim). Based on that aspect of his claim he sought orders rectifying the register of patents.
5 A few months before commencement by Mr Sharif of proceedings in this Court, Vitruvian had commenced proceedings in the Supreme Court of Western Australia in which it sought relief declaring that the cancellation of the shares of Mr Sharif that had occurred almost two years earlier was not invalid. Vitruvian also sought an order pursuant to s 1322(4)(c) of the Corporations Act relieving its directors and officers from any civil liability arising out of the share cancellation (Section 1322 Application). On 26 July 2022, those proceedings were ordered to be transferred to this Court.
6 After the transfer, orders were made by this Court for Mr Sharif to be joined as a defendant to the Section 1322 Application and for the two sets of proceedings to be case managed together. Orders were also made for a joint trial of the two proceedings and for evidence in one proceeding to be evidence in the other. The trial was expedited.
7 On 20 April 2023, Mr Sharif applied to amend his statement of claim in the proceedings brought by him and also to amend his defence to the Section 1322 Application (Amendment Application). I heard and determined the Amendment Application on 4 May 2023. The application was allowed on the basis that Mr Sharif would pay the costs of the amendment applications and the costs thrown away by reason of the amendments.
8 Broadly speaking, the amendments added a claim by Mr Sharif that there was an implied term of the shareholder's agreement by which he was entitled to participate pro rata in any share issue by Vitruvian. Leave was also given to delete the Patent Claim. The amendments were allowed at a time when witness statements had been exchanged between the parties. Much of the content of those statements concerned the competing accounts of the circumstances in which the fitness device had been conceived and developed.
9 At about the same time as the Amendment Application, Mr Sharif also sought to inspect a number of documents in respect of which the Vitruvian Defendants claimed legal professional privilege (Inspection Application). He brought an application for orders for inspection. His application was refused: Vitruvian Investments Pty Ltd v Sharif [2023] FCA 471.
10 The trial of the proceedings took place between 29 May and 1 June 2023. Reasons were delivered in August 2023: Sharif v Vitruvian Investments Pty Ltd (No 3) [2023] FCA 920 (Trial Reasons). In the conclusion to those reasons, I said (at [330]):
For the above reasons, the application by Vitruvian for orders pursuant to s 1322 of the Corporations Act must be dismissed with costs. The application by Mr Sharif for orders as provided for in s 233 on the basis of oppressive conduct contrary to s 232 should be allowed. The appropriate order to be made is to require J & S Gregory Pty Ltd to transfer three million shares in Vitruvian to Mr Sharif before the issue of any further shares by Vitruvian. The transfer should occur without consideration payable by Mr Sharif. There should be an order for costs in favour of Mr Sharif but that order will need to allow for the extent to which claims were not pursued. It should have regard to materials that the parties have been directed to file as to the question of costs.
11 Three million shares equated to 8% of the ordinary shares in Vitruvian.
12 The reference in the above conclusion to materials that the parties had been directed to file as to costs was a reference to materials filed pursuant to orders made on 9 June 2023 requiring the parties to file and serve:
(1) a statement of the legal costs and disbursements that had been incurred in the conduct of the proceedings (including costs incurred while the proceedings were being conducted in the Supreme Court of Western Australia), together with a breakdown of those costs that will assist in assessing their reasonableness; and
(2) submissions of no more than five pages setting out the quantum of costs that the party would seek on a lump sum basis in the event that the proceedings were determined favourably to that party and costs were assessed on a lump sum basis, together with any submissions as to whether costs should be assessed on a lump sum basis by reference to the statement of legal costs and disbursements provided in accordance with the orders.
13 The cost summary filed by Mr Sharif pursuant to those orders listed all of the costs and disbursements that had been incurred by Mr Sharif. It contended that an amount of $1,419,382.74 (inclusive of GST) would be an appropriate figure for a lump sum costs order in favour of Mr Sharif if he was successful. That figure was approximately 87% of the costs said to have been incurred. The costs incurred included an amount of $771,879.90 (inclusive of GST) that had been charged by Squire Patton Boggs who had acted for Mr Sharif in the proceedings up until the end of January 2023. Thereafter, Hall & Wilcox acted for Mr Sharif. The significance of the amount included for charges by Squire Patton Boggs is addressed below.
14 The cost summary filed by the Vitruvian Defendants identified the costs charged to Vitruvian in respect of the Section 1322 Application when it was being conducted in the Supreme Court as being $106,223 (inclusive of GST). It stated that when the Section 1322 Application had been transferred to this Court, Bennett, the lawyers acting for the Vitruvian Defendants, thereafter had recorded all of the time charges on a single file which related to both proceedings in this Court. The total costs incurred for the period after the transfer were said to have been $1,019,011.64 (inclusive of GST). The combined figure was $1,125,234.64. It was submitted for the Vitruvian Defendants that if it was appropriate that costs be awarded on a standard party and party basis, the appropriate order was for Mr Sharif to pay the Vitruvian Defendants a lump sum of $726,818.85 (excluding GST), being an amount of $799,500.73 (inclusive of GST).
15 In the short submissions filed with the cost summaries, all parties supported the making of a lump sum costs order.
16 Usually, the costs incurred by a claimant who bears the onus might be expected to exceed the costs of a responding party. However, even if Mr Sharif is viewed, in substance, as the claimant, the disparity between the two costs amount is considerable.
17 After the judgment was delivered, two issues arose. First, there was a dispute as to the terms in which orders should be made to give effect to the transfer of shares by J & S Gregory Pty Ltd to Mr Sharif. Second, there was a dispute as to the quantum of the lump sum order (which dispute encompassed a claim by Mr Sharif that the lump sum assessment should be undertaken on an indemnity basis).
18 I determined the dispute as to the orders: Sharif v Vitruvian Investments Pty Ltd (No 4) [2023] FCA 1172. There remains the issue of the lump sum costs assessment. These reasons concern that issue.
19 There is no dispute that Mr Sharif was substantially successful and that there should be a lump sum costs order in his favour. Various matters are said to bear upon how that lump sum assessment should be undertaken. They include some offsetting claims to costs by the Vitruvian Defendants.
20 There is also an issue as to whether there should be a single lump sum assessment as to all of the costs which should be ordered to be paid by all of the Vitruvian Defendants or whether there should be some separate identification of the costs of the Section 1322 Application with those costs to be ordered to be paid by Vitruvian only.
21 The issues that arise are as follows:
(1) Should the lump sum assessment be made on an indemnity basis?
(2) If costs are to be assessed on an indemnity basis should there be any adjustment on the basis that costs were unreasonably incurred or were unreasonable in amount?
(3) What should occur in relation to the costs incurred in resolving the dispute as to the terms in which the relief as to the transfer of shares by J & S Gregory Pty Ltd to Mr Sharif should be expressed?
(4) Having regard to events that have occurred in relation to the costs charged by Squire Patton Boggs to Mr Sharif since the cost summaries were provided, what is the proper approach to those costs in undertaking the lump sum assessment?
(5) Should an adjustment be made on the basis that some of the costs that are sought to be recovered concern work undertaken by fee earners whose names do not appear on the Register of Practitioners kept by the High Court of Australia?
(6) What provision should be made for the costs of the Amendment Application?
(7) What provision should be made for the costs thrown away by reason of the withdrawal of the Patent Claim by Mr Sharif?
(8) What provision should be made for the costs of the Inspection Application?
(9) Should an adjustment be made as to the costs that may be recovered by Mr Sharif on the basis that there was inadequate disclosure by Hall & Wilcox of the costs that were likely to be incurred by Mr Sharif in the conduct of the proceedings?
(10) Should the lump sum order in favour of Mr Sharif be made against all the Vitruvian Defendants?
(11) Having regard to the resolution of the above issues, in what amount should the lump sum assessment be made?
(12) What provision should be made in the lump sum assessment for the costs of and incidental to the determination of the appropriate amount for the lump sum costs order?